These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 15778602)

  • 21. Role of topical interferon alpha-2b in 'mitomycin-C-resistant' ocular surface squamous neoplasia: our preliminary findings.
    Singh M; Gautam N; Kaur M
    Int Ophthalmol; 2019 Feb; 39(2):295-301. PubMed ID: 29362973
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study.
    Parrozzani R; Lazzarini D; Alemany-Rubio E; Urban F; Midena E
    Br J Ophthalmol; 2011 Mar; 95(3):355-9. PubMed ID: 20693564
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia: a systematic review.
    Viani GA; Fendi LI
    Arq Bras Oftalmol; 2017; 80(2):131-136. PubMed ID: 28591290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of surgical wide excision and amniotic membrane transplantation with adjuvant topical mitomycin C treatment in recurrent conjunctival--corneal intraepithelial neoplasia.
    Lee JH; Kim YH; Kim MS; Kim EC
    Semin Ophthalmol; 2014 Jul; 29(4):192-5. PubMed ID: 23971714
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk factors for ocular surface squamous neoplasia recurrence after treatment with topical mitomycin C and interferon alpha-2b.
    Besley J; Pappalardo J; Lee GA; Hirst LW; Vincent SJ
    Am J Ophthalmol; 2014 Feb; 157(2):287-293.e2. PubMed ID: 24184223
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ultra high-resolution anterior segment optical coherence tomography in the diagnosis and management of ocular surface squamous neoplasia.
    Thomas BJ; Galor A; Nanji AA; El Sayyad F; Wang J; Dubovy SR; Joag MG; Karp CL
    Ocul Surf; 2014 Jan; 12(1):46-58. PubMed ID: 24439046
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon alpha 2b treatment for residual ocular surface squamous neoplasia unresponsive to excision, cryotherapy and mitomycin-C.
    Nemet AY; Sharma V; Benger R
    Clin Exp Ophthalmol; 2006; 34(4):375-7. PubMed ID: 16764660
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ocular Surface Squamous Neoplasia in Papillon-Lefèvre Syndrome: Outcome at Long-Term Follow-Up of 12 Years.
    Kaliki S; Singh S; Gowrishankar S; Reddy VAP
    Cornea; 2017 Jun; 36(6):743-746. PubMed ID: 28350623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, treatment, and outcomes of coexistent ocular surface squamous neoplasia and pterygium.
    Oellers P; Karp CL; Sheth A; Kao AA; Abdelaziz A; Matthews JL; Dubovy SR; Galor A
    Ophthalmology; 2013 Mar; 120(3):445-450. PubMed ID: 23107578
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of combination therapy of topical mitomycin C and cyclosporine a as an adjunct to surgery for corneal and conjunctival intraepithelial neoplasia and invasive squamous cell carcinoma.
    Sugandhi P; George RE
    Cornea; 2011 Apr; 30(4):486; author reply 486-7. PubMed ID: 21107255
    [No Abstract]   [Full Text] [Related]  

  • 31. Surgery Versus Interferon Alpha-2b Treatment Strategies for Ocular Surface Squamous Neoplasia: A Literature-Based Decision Analysis.
    Siedlecki AN; Tapp S; Tosteson AN; Larson RJ; Karp CL; Lietman T; Zegans ME
    Cornea; 2016 May; 35(5):613-8. PubMed ID: 26890663
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumors of the cornea and conjunctiva.
    Spraul CW; Grossniklaus HE
    Curr Opin Ophthalmol; 1996 Aug; 7(4):28-34. PubMed ID: 10163636
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Topical 5-fluorouracil 1% for moderate to extensive ocular surface squamous neoplasia in 73 consecutive patients: Primary versus secondary treatment.
    Leventer I; Singh H; Pashaee B; Raimondo CD; Khakh CK; Martin JL; Acharya B; Zhang Q; Lally SE; Shields CL
    Asia Pac J Ophthalmol (Phila); 2024; 13(2):100052. PubMed ID: 38521390
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ocular surface squamous neoplasia.
    Pe'er J
    Ophthalmol Clin North Am; 2005 Mar; 18(1):1-13, vii. PubMed ID: 15763187
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Surgical versus Medical Treatment of Ocular Surface Squamous Neoplasia: A Cost Comparison.
    Moon CS; Nanji AA; Galor A; McCollister KE; Karp CL
    Ophthalmology; 2016 Mar; 123(3):497-504. PubMed ID: 26686965
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunosuppression as a Possible Risk Factor for Interferon Nonresponse in Ocular Surface Squamous Neoplasia.
    Ashkenazy N; Karp CL; Wang G; Acosta CM; Galor A
    Cornea; 2017 Apr; 36(4):506-510. PubMed ID: 28129301
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Topical interferon alfa-2b for the treatment of recalcitrant ocular surface squamous neoplasia.
    Holcombe DJ; Lee GA
    Am J Ophthalmol; 2006 Oct; 142(4):568-71. PubMed ID: 17011846
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo confocal microscopy study of ocular surface neoplasia manifesting after radial keratotomy and laser in situ keratomileusis.
    Gentile CM; Burchakchi AI; Oscar CJ
    Cornea; 2009 Apr; 28(3):357-9. PubMed ID: 19387244
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution.
    Hirst LW
    Ophthalmology; 2007 May; 114(5):976-82. PubMed ID: 17241666
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatment of ocular surface squamous neoplasia in an Indian rural facility: a study of 38 eyes.
    Agarwal A; Ghose N; Rathi V; Khanna R; Kaliki S
    BMC Ophthalmol; 2024 Sep; 24(1):389. PubMed ID: 39227791
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.